Case File №
#VI-2026-0070
Zhang TY
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
38 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | A Great | 3 | 8.1 | 7.3 | 9.3 | 30 Jun 2025 |
| Tesamorelin | X Unrated | 1 | 1.5 | 1.5 | 1.5 | 29 Jun 2025 |
| 5-amino-1MQ | X N/A | 1 | 4.0 | 4.0 | 4.0 | 25 Apr 2025 |
| Anavar (Oxandrolone) | X N/A | 1 | 7.1 | 7.1 | 7.1 | 16 Mar 2025 |
| Andarine S4 | X N/A | 1 | 4.2 | 4.2 | 4.2 | 9 Jun 2025 |
| ARA-290 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 4.0 | 3.6 | 3.6 | 6 May 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 6.8 | 6.8 | 6.8 | 6 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 4.9 | 4.9 | 4.9 | 21 May 2025 |
| Cardiogen | X N/A | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 4.6 | 4.6 | 4.6 | 3 Jun 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 6.7 | 6.7 | 6.7 | 13 Feb 2025 |
| Dianabol Raw | X N/A | 1 | 5.8 | 5.8 | 5.8 | 20 Jun 2025 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 7.8 | 7.8 | 7.8 | 16 Mar 2025 |
| Dutasteride | X N/A | 1 | 6.1 | 6.1 | 6.1 | 27 Feb 2025 |
| EPO | X N/A | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 |
| Fluoxymesterone (Halotestin) Raw | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| GHRP-6 Acetate | X N/A | 1 | 7.0 | 7.0 | 7.0 | 25 Apr 2025 |
| Humanin | X N/A | 1 | 6.6 | 6.6 | 6.6 | 11 Jun 2025 |
| Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | X N/A | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 |
| Masteron E (Drostanolone E) | X N/A | 1 | 9.0 | 9.0 | 9.0 | 6 May 2025 |
| NA Selank Amidate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 8.5 | 8.5 | 8.5 | 20 Jun 2025 |
| NAD+ | X N/A | 1 | 5.2 | 5.2 | 5.2 | 3 Jul 2025 |
| Oxytocin Acetate | X N/A | 1 | 8.9 | 8.9 | 8.9 | 9 Jun 2025 |
| P21 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 25 Apr 2025 |
| PEG MGF | X N/A | 1 | 6.6 | 6.6 | 6.6 | 14 Jan 2025 |
| S-23 Raw | X N/A | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 |
| Salbutamol | X N/A | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 |
| Selank | X N/A | 1 | 8.1 | 8.1 | 8.1 | 20 Jun 2025 |
| SNAP-8 | X N/A | 1 | 6.8 | 6.8 | 6.8 | 14 Jan 2025 |
| Super Shred | X N/A | 1 | 8.5 | 8.5 | 8.5 | 2 Jul 2025 |
| T3 (Liothyronine) | X N/A | 1 | 6.7 | 6.7 | 6.7 | 16 Mar 2025 |
| Trenbolone Acetate | X N/A | 1 | 4.0 | 3.9 | 3.9 | 16 Mar 2025 |
| Trenbolone Enanthate | X N/A | 1 | 6.6 | 6.6 | 6.6 | 24 Apr 2025 |
| Trestolone Enanthate Raw | X N/A | 1 | 4.4 | 4.4 | 4.4 | 11 Jun 2025 |
| Vilon | X N/A | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 |
| Vitamin B12 10mg/ml | X N/A | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 |
Exhibit II
Evidence Log
40 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 9.2 A | 50mg | 56.5mg | +13.0% | 97.73% | iul90v | Lab B | Public |
| 25 May 2026 | Trenbolone Acetate | 4.0 C | 300mg/ml | 337.7mg/ml | +12.6% | 99.27% | l15w3c | Lab F | Public |
| 24 May 2026 | Vilon | 6.5 A | 15mg | 14.1mg | -6.2% | 95.27% | osducr | Lab C | Community |
| 24 May 2026 | Super Shred | 8.6 A | 300mg/ml | 325.9mg/ml | +8.6% | 96.46% | oqfubg | Lab F | Public |
| 24 May 2026 | Cardiogen | 8.8 A | 2mg | 1.7mg | -13.5% | 98.54% | pibw25 | Lab C | Community |
| 24 May 2026 | EPO | 6.5 A | 30mg | 34.7mg | +15.8% | 98.40% | 4ck1wg | Lab E | Community |
| 24 May 2026 | P21 | 6.5 A | 5mg | 5.4mg | +7.9% | 98.14% | hkfs9p | Lab A | Public |
| 24 May 2026 | Selank | 7.0 A | 2mg | 1.8mg | -11.1% | 99.95% | 01g25u | Lab E | Community |
| 24 May 2026 | Trenbolone Enanthate | 5.2 B | 200mg/ml | 234.0mg/ml | +17.0% | 98.11% | 5iwu1y | Lab B | Community |
| 23 May 2026 | Trestolone Enanthate Raw | 4.0 C | 10g | 9.2g | -7.9% | 97.95% | 8yucod | Lab A | Community |
| 21 May 2026 | BPC157 5mg + TB500 5mg Blend | 4.4 C | 10mg | 10.2mg | +2.1% | 98.34% | lxi8jz | Lab F | Community |
| 21 May 2026 | Salbutamol | 5.9 B | 100mg | 117.7mg | +17.7% | 99.88% | j94w7a | Lab E | Community |
| 20 May 2026 | 5-amino-1MQ | 4.0 C | 2mg | 1.8mg | -8.2% | 95.01% | r1c1f5 | Lab D | Public |
| 20 May 2026 | Drostanolone Propionate (Mast P) Raw | 8.1 A | 500g | 517.8g | +3.6% | 98.83% | tlc5md | Lab G | Public |
| 20 May 2026 | GHRP-6 Acetate | 7.2 A | 10mg | 10.6mg | +6.4% | 98.54% | bpolf0 | Lab B | Community |
| 19 May 2026 | Fluoxymesterone (Halotestin) Raw | 6.9 A | 500g | 598.5g | +19.7% | 99.58% | p2nwb0 | Lab A | Community |
| 19 May 2026 | NA Selank Amidate | 5.8 B | 15mg | 14.4mg | -3.8% | 99.79% | pw51qp | Lab D | Public |
| 17 May 2026 | T3 (Liothyronine) | 6.5 A | 10mg | 11.3mg | +12.6% | 96.37% | gz5nbr | Lab G | Community |
| 29 Jan 2026 | S-23 Raw | 5.8 B | 5g | 4.3g | -14.1% | 97.71% | yemgko | Lab B | Community |
| 29 Jan 2026 | SNAP-8 | 7.4 A | 5mg | 4.4mg | -12.3% | 99.74% | bq2q1j | Lab F | Public |
| 7 Jan 2026 | Retatrutide | 9.3 A | 10mg | 10.3mg | +3.0% | 99.60% | 2510270012 | Lab G | Public |
| 7 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 5.1 B | 500g | 453.5g | -9.3% | 95.94% | nvogns | Lab D | Public |
| 29 Dec 2025 | Masteron E (Drostanolone E) | 8.7 A | 200mg/ml | 191.2mg/ml | -4.4% | 97.02% | 78prqj | Lab F | Public |
| 12 Dec 2025 | Dianabol Raw | 4.0 C | 10g | 10.7g | +7.3% | 97.65% | sr4h4u | Lab C | Public |
| 12 Dec 2025 | Humanin | 7.2 A | 15mg | 12.8mg | -15.0% | 95.08% | p0pz3q | Lab A | Public |
| 5 Dec 2025 | Andarine S4 | 4.3 C | 100mg | 118.4mg | +18.4% | 99.14% | v67lz5 | Lab G | Community |
| 5 Dec 2025 | PEG MGF | 5.1 B | 5mg | 4.7mg | -5.7% | 96.89% | 5k73ra | Lab G | Community |
| 23 Nov 2025 | Oxytocin Acetate | 7.9 A | 20mg | 21.1mg | +5.6% | 97.03% | ky8w8d | Lab E | Community |
| 17 Nov 2025 | Anavar (Oxandrolone) | 6.4 A | 50mg | 44.6mg | -10.8% | 97.72% | jgwgwr | Lab D | Public |
| 17 Nov 2025 | ARA-290 | 5.1 B | 5mg | 4.4mg | -12.1% | 98.52% | zgs1dx | Lab E | Community |
| 14 Nov 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 5.0 B | 30mg | 28.0mg | -6.8% | 99.11% | dfz9w9 | Lab E | Community |
| 14 Nov 2025 | NAD+ | 5.7 B | 30mg | 33.1mg | +10.2% | 97.98% | xljgex | Lab B | Public |
| 4 Nov 2025 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 8.0 A | 10mg | 12.5mg | +24.9% | 99.88% | 3uq3u7 | Lab A | Public |
| 17 Oct 2025 | Vitamin B12 10mg/ml | 4.5 C | 100mg/ml | 97.9mg/ml | -2.1% | 99.58% | fd8jjd | Lab G | Public |
| 9 Oct 2025 | Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) | 6.7 A | 300mg/ml | 292.1mg/ml | -2.6% | 96.01% | 2vjnnd | Lab D | Community |
| 3 Oct 2025 | Cerebrolysin | 6.3 A | 5mg | 5.7mg | +14.9% | 97.41% | gf7wwp | Lab A | Community |
| 3 Oct 2025 | Dutasteride | 6.1 A | 100mg | 108.6mg | +8.6% | 96.62% | 9i5vwk | Lab A | Community |
| 11 Aug 2025 | Retatrutide | 7.7 A | 30mg | 28.2mg | -6.0% | 99.95% | (no batch ID) | Lab E | Public |
| 30 Jun 2025 | Retatrutide | 7.3 A | 20mg | 20.8mg | +4.0% | 99.62% | (no batch ID) | Lab E | Public |
| 29 Jun 2025 | Tesamorelin | 1.5 E | 10mg | 5.89mg | -41.1% | 76.28% | (no batch ID) | Lab E | Public |
— END OF EVIDENCE LOG —